Jeffrey F. McKelvy
Director/Miembro de la Junta en Thuris Corp. .
Origen de la red de primer grado Jeffrey F. McKelvy.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Avera Pharmaceuticals, Inc.
 Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA.
11
| Extinct | Medical/Nursing Services | 11 |
Thuris Corp.
 Thuris Corp. Medical SpecialtiesHealth Technology Thuris Corp. develops medical devices. It develops pharmaceuticals for CNS Orphan and niche indications including, a stroke-related condition, peripheral neuropathy and Huntington's disease. It develops pharmaceuticals for cluster headaches, depression and mild cognitive impairment, a precursor of Alzheimer's disease. The company is also developing a non-invasive medical device that will assist in the diagnosis of psychiatric and neurological disorders over a broad range of brain-related conditions. Thuris is headquartered in Irvine, CA.
5
| Subsidiary | Medical Specialties | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jeffrey F. McKelvy a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | President Founder Corporate Officer/Principal | |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Biotechnology | Sales & Marketing General Counsel | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Dartmouth College | College/University | Undergraduate Degree | |
General Atomics, Inc.
 General Atomics, Inc. Electrical ProductsProducer Manufacturing General Atomics develops and manufactures high-technology products for commercial, and government applications. It offers nuclear fuel cycle, electromagnetic systems, remotely operated surveillance aircraft, airborne sensors, and high-power lasers. The company was founded in 1955 and is headquartered in San Diego, CA. | Electrical Products | Corporate Officer/Principal | |
Ancile Pharmaceuticals, Inc.
 Ancile Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ancile Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. The private company is based in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree | |
| Princeton University | College/University | Doctorate Degree | |
| University of California, Irvine | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of San Diego | College/University | Undergraduate Degree | |
| Georgetown University | College/University | Doctorate Degree Undergraduate Degree | |
| National Aeronautics & Space Administration | General Government | Corporate Officer/Principal | |
Windamere Venture Partners LLC
 Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Jet Propulsion Laboratory
 Jet Propulsion Laboratory Miscellaneous Commercial ServicesCommercial Services Jet Propulsion Laboratory operates a national research facility. It is a federally funded research and development center. The firm specializes in robotic space and Earth science missions. The company was founded by Frank Malina, Ed Forman, and Jack Parsons on October 31, 1936 and is headquartered in Pasadena, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Director/Board Member | |
| MD Edge, Inc. | Corporate Officer/Principal Director of Finance/CFO | ||
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
| PFENEX INC. | Biotechnology | Director of Finance/CFO | |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| Didyma LLC | Corporate Officer/Principal | ||
| Columbia Business School | College/University | Masters Business Admin | |
| EVOFEM BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
Spybiotech Ltd.
 Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman | |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Recida Therapeutics, Inc.
 Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Founder | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Founder | |
| HISTOGEN INC. | Biotechnology | Chairman Chief Executive Officer | |
Proteas Bioanalytics, Inc.
 Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation. | Internet Software/Services | Director/Board Member | |
| HILLEVAX, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
IpiNovyx Bio, Inc.
 IpiNovyx Bio, Inc. Medical/Nursing ServicesHealth Services IpiNovyx Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat autoimmune and inflammatory diseases through selective inhibition of the immunoproteasome. The company is based in West Nyack, NY. The company's platform technology enables highly selective, reversible, and non-toxic inhibition of various immune cell types, with applications across a range of indications with underlying immunopathology. Orange Grove Bio (OGB) is an emerging, preclinical, capital allocation, and asset development biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company was founded by Jim Graham, and the CEO is Marc Appel. | Medical/Nursing Services | Director/Board Member | |
Orange Grove Bio LLC
 Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Financial Conglomerates | Chairman | |
| Universidade De Sao Paulo Faculdade De Medicina | College/University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 45 |
| Israel | 2 |
| Alemania | 2 |
| Taiwán | 2 |
| Suiza | 2 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 4 |
Operativa
| Director/Board Member | 81 |
| Corporate Officer/Principal | 54 |
| Founder | 24 |
| Independent Dir/Board Member | 21 |
| Chief Tech/Sci/R&D Officer | 17 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Patrick Heron | 42 |
| Dan Kisner | 29 |
| David Socks | 24 |
| Lutz B. Giebel | 21 |
| Joao Siffert | 14 |
| Vincent Simmon | 13 |
| Susan Knudson | 13 |
| Bernard King | 13 |
| Bret E. Megargel | 9 |
| Bill Pitlick | 9 |
| Dinu Sen | 8 |
| Gary S. Lynch | 7 |
| Keith B. Hoffman | 6 |
| Nadine Knowles | 5 |
| Richard Granger | 4 |
- Bolsa de valores
- Insiders
- Jeffrey F. McKelvy
- Conexiones Empresas
